MiR-145-5p and MiR-203a-5p Overcome Imatinib Resistance in Myelogenous Leukemic Cells through Metabolic Reprogramming. IJBB 2023, 60 (3), 167-176. https://doi.org/10.56042/ijbb.v60i3.66526.